SCHEMBL977511

SCHEMBL977511

Cc1nc(C)c(C(=O)Nc2ccccc2-c2cc(F)c(F)cc2F)s1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.55
RECQL P46063 1/20 0.55
KMT2A Q03164 7/20 0.53
MEN1 O00255 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.51
NPC1 O15118 3/20 0.51
TP53 P04637 1/20 0.51
CHRNA7 P36544 1/20 0.47
BACE1 P56817 1/20 0.46
MAPT P10636 1/20 0.45
F10 P00742 1/20 0.45
GAA P10253 3/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL978883 0.86 MAPT (0.47) RAB9ARECQLKMT2AMEN1SMN1; SMN2
SCHEMBL27713400 0.86 RAB9A (0.55) RAB9ARECQLKMT2AMEN1SMN1; SMN2
SCHEMBL975700 0.85 KMT2A (0.55) RAB9ARECQLKMT2AMEN1SMN1; SMN2
SCHEMBL10213374 0.81 KMT2A (0.52) RAB9ARECQLKMT2AMEN1SMN1; SMN2
SCHEMBL2911294 0.81 CHRM3 (0.45) RAB9ARECQLKMT2AMEN1SMN1; SMN2
SCHEMBL13210660 0.79 F10 (0.53) RAB9ARECQLKMT2AMEN1SMN1; SMN2
SCHEMBL13210780 0.79 KMT2A (0.55) RAB9ARECQLKMT2AMEN1SMN1; SMN2
SCHEMBL13210663 0.79 RAB9A (0.59) RAB9ARECQLKMT2AMEN1SMN1; SMN2
SCHEMBL12263907 0.78 RAB9A (0.58) RAB9ARECQLKMT2AMEN1SMN1; SMN2
SCHEMBL10213378 0.77 L3MBTL1 (0.57) RAB9ARECQLKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1888545-B1 THIAZOLE CARBOXYLIC ACID ANILIDES BASF SE (DE) 2010-08-25 EP claimed
US-20090099019-A1 Thiazolecarboxanilides BASF AKTIENGESELLSCHAFT (DE) 2009-04-16 US claimed
US-20110004021-A1 THIAZOLECARBOXANILIDES DIETZ JOCHEN 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110004021-A1 THIAZOLECARBOXANILIDES CBR3, CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 RAB9A 4174/4885RECQL 2730/4885KMT2A 1147/4885
US-20090099019-A1 Thiazolecarboxanilides CBR3, CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 RAB9A 4174/4885RECQL 2730/4885KMT2A 1147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.